Dr. Hurwitz et al., SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE OR HUMAN FACTOR-IX IN DOGS BY REINTRODUCED GENETICALLY-MODIFIED AUTOLOGOUS BONE-MARROW STROMAL CELLS, Human gene therapy, 8(2), 1997, pp. 137-156
Canine bone marrow stromal cells were expanded to numbers in excess of
10(9) cells from the initial 10-20 ml of marrow aspirates and transfe
cted to express high levels of human growth hormone (hGH) in vitro. Ex
vivo-modified marrow stromal cells were used in a gene therapy model
system for the systemic delivery of transgene products in dogs. Adhere
nt bone marrow stromal cell cultures, established and expanded from il
iac crest marrow aspirates from each of 8 dogs, were transfected with
a hGH gene plasmid expression vector and shown to express from 0.54-3.
84 mu g/10(6) cells per 24 hr hGH in vitro. The transfected plasmid ve
ctor does not possess a eukaryotic origin of replication nor does it p
ossess sequences required for efficient integration into the host cell
genome. As such, expression was expected to be transient. Transfected
cells were autologously reintroduced into each dog by either infusion
into a foreleg vein or directly into iliac crest marrow. In two cases
, the stromal cells were cryopreserved following transfection, and sub
sequently thawed and infused. In one case, the expanded stromal cells
were first cryopreserved, and then thawed, recultured, transfected, an
d infused. Reintroduced cell numbers ranged from 2.2 x 10(7) to 2.6 x
10(9), with total hGH expression capacities ranging from 62 to 1,400 m
u g/24 hr. Plasma of each of the dogs contained detectable hGH for a m
ean of 3.1 days (SD +/- 0.8 day) ranging from 2 to 5 days following re
infusion of cells. Peak plasma levels ranged from 0.10 to 1.76 ng/ml.
Similar hGH expression values, based upon total expression capacity of
the cells infused and dog body weight, were obtained for all dogs. Ve
ctor-modified stromal cells were detectable, by polymerase chain react
ion (PCR) analysis, in the peripheral circulation following reinfusion
in all 4 dogs analyzed. In 3 of the dogs, modified stromal cells were
detected for 8.5-15 weeks. In addition, modified stromal cells were d
etected in iliac crest marrow of 2 dogs for 9 and 13 weeks, respective
ly, following reinfusion. Tn another experiment, cultured bone marrow
stromal cells were transfected with a human factor IX (hFIX) plasmid v
ector. Modified cells (5.57 x 10(8)), with a total hFIX expression cap
acity of 281 mu g/24 hr, were reinfused, resulting in detectable hFIX
in plasma continuously for 9 days with a peak level of 8 ng/ml on day
1. These results demonstrate that the ex vivo bone marrow stromal cell
system is a potentially powerful method by which to deliver secreted
transgene product to the systemic circulation of large animals.